IRIS Accounts Production v25.1.0.734 05692122 director 1.4.24 31.3.25 31.3.25 0 0 true false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh056921222024-03-31056921222025-03-31056921222024-04-012025-03-31056921222023-03-31056921222023-04-012024-03-31056921222024-03-3105692122ns15:EnglandWales2024-04-012025-03-3105692122ns14:PoundSterling2024-04-012025-03-3105692122ns10:Director12024-04-012025-03-3105692122ns10:PrivateLimitedCompanyLtd2024-04-012025-03-3105692122ns10:SmallEntities2024-04-012025-03-3105692122ns10:AuditExempt-NoAccountantsReport2024-04-012025-03-3105692122ns10:SmallCompaniesRegimeForDirectorsReport2024-04-012025-03-3105692122ns10:SmallCompaniesRegimeForAccounts2024-04-012025-03-3105692122ns10:AbridgedAccounts2024-04-012025-03-3105692122ns10:CompanySecretary12024-04-012025-03-3105692122ns10:RegisteredOffice2024-04-012025-03-3105692122ns5:CurrentFinancialInstruments2025-03-3105692122ns5:CurrentFinancialInstruments2024-03-3105692122ns5:ShareCapital2025-03-3105692122ns5:ShareCapital2024-03-3105692122ns5:RetainedEarningsAccumulatedLosses2025-03-3105692122ns5:RetainedEarningsAccumulatedLosses2024-03-31
REGISTERED NUMBER: 05692122 (England and Wales)















DELPH MEDICAL PRODUCTS HOLDINGS LIMITED

UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED

31 MARCH 2025






DELPH MEDICAL PRODUCTS HOLDINGS LIMITED (REGISTERED NUMBER: 05692122)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025










Page

Company Information 1

Abridged Balance Sheet 2

Notes to the Financial Statements 3


DELPH MEDICAL PRODUCTS HOLDINGS LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 MARCH 2025







DIRECTOR: D S Coney





SECRETARY: P J Coney





REGISTERED OFFICE: 2 Colby Drive
Thurmaston
Leicester
Leicestershire
LE4 8LA





REGISTERED NUMBER: 05692122 (England and Wales)






DELPH MEDICAL PRODUCTS HOLDINGS LIMITED (REGISTERED NUMBER: 05692122)

ABRIDGED BALANCE SHEET
31 MARCH 2025

2025 2024
Notes £    £    £   
FIXED ASSETS
Investments 4 370,000 370,000

CURRENT ASSETS
Cash at bank 1,891 1,863

CREDITORS
Amounts falling due within one year 121,439 159,434
NET CURRENT LIABILITIES (119,548 ) (157,571 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

250,452

212,429

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings 250,352 212,329
SHAREHOLDERS' FUNDS 250,452 212,429

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

All the members have consented to the preparation of an abridged Balance Sheet for the year ended 31 March 2025 in accordance with Section 444(2A) of the Companies Act 2006.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 13 May 2025 and were signed by:





D S Coney - Director


DELPH MEDICAL PRODUCTS HOLDINGS LIMITED (REGISTERED NUMBER: 05692122)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025


1. STATUTORY INFORMATION

Delph Medical Products Holdings Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

The accounts have been prepared on the going concern basis notwithstanding the company's net current liabilities of £159140. Included in creditors is a loan from the director of £59,612 which has no formal repayment terms. The director confirms he will offer continuing support to the company for the next twelve months to enable it to meet its liabilities.

Investments in subsidiaries
Investments in subsidiary undertakings are recognised at cost.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was NIL (2024 - NIL).

4. FIXED ASSET INVESTMENTS

Information on investments other than loans is as follows:
Totals
£   
COST
At 1 April 2024
and 31 March 2025 370,000
NET BOOK VALUE
At 31 March 2025 370,000
At 31 March 2024 370,000